Abstract
Cefoxitin, a β-lactamase-resistant cephalosporin, was found to be more effective than cephalothin against an experimental mixed infection containing Bacteroides fragilis and Fusobacterium necrophorum.
Full text
PDF

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Hackman A. S., Wilkins T. D. In vivo protection of Fusobacterium necrophorum from penicillin by Bacteroides fragilis. Antimicrob Agents Chemother. 1975 May;7(5):698–703. doi: 10.1128/aac.7.5.698. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wallick H., Hendlin D. Cefoxitin, a semisynthetic cephamycin antibiotic: susceptibility studies. Antimicrob Agents Chemother. 1974 Jan;5(1):25–32. doi: 10.1128/aac.5.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilkins T. D., Smith L. D. Chemotherapy of an experimental Fusobacterium (Sphaerophorus) necrophorum infection in mice. Antimicrob Agents Chemother. 1974 Jun;5(6):658–662. doi: 10.1128/aac.5.6.658. [DOI] [PMC free article] [PubMed] [Google Scholar]
